
On April 1st, 2020, the US Food and Drug Administration (FDA) recalled all Zantac and ranitidine products from the market due to substantial evidence linking the drug to hazardous levels of the carcinogenic chemical N-nitrosodimethylamine, or NDMA. As a result, tens of thousands of former Zantac users have come forward to proceed with legal action …

